Skip to content

13F-HR/A filed by COURAGE CAPITAL MANAGEMENT LLC

COURAGE CAPITAL MANAGEMENT LLC filed this 13F-HR/A for the quarter ended 2017-12-31, filed 2018-03-19, with 26 holding rows worth $139,805,000.

Accession
0001140361-18-013948
Filed
2018-03-19
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2017

A holdings report, amendment of type restatement, 27 entries on the cover page, a total value of $139,805,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $139,805,000 with VALUE read as thousands by filing date, 13F file number 028-10362. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
ALTABA INC021346101COM1,200,000$83,820,000thousands by filing date
VEREIT INC92339V100COM1,975,000$15,385,000thousands by filing date
ACADIA HEALTHCARE COMPANY INC COM00404A109Stock280,000$9,136,000thousands by filing date
Alphabet Inc. Reg. Shares C02079K107COM8,500$8,894,000thousands by filing date
VALEANT PHARMACEUTICALS INTL91911K102COM250,000$5,195,000thousands by filing dateput
MICHAEL KORS HLDGS LTDG60754101SHS50,000$3,148,000thousands by filing date
NOVOCURE LTDG6674U108ORD SHS100,000$2,020,000thousands by filing date
FIESTA RESTAURANT GROUP INC31660B101COM98,724$1,876,000thousands by filing date
PG&E CORP COM69331C108Stock40,900$1,735,000thousands by filing datecall
META PLATFORMS INC CL A30303M102COM9,000$1,588,000thousands by filing date
SPY78462F103SHS11,500$1,422,000thousands by filing date
CONATUS PHARMACEUTICALS INC20600T108COM200,000$924,000thousands by filing date
DBV TECHNOLOGIES S A23306J101ADR30,000$738,000thousands by filing date
JONES ENERGY INC48019R908COM CL A25,000$656,000thousands by filing date
Walmart Inc.931142103COM5,550$548,000thousands by filing date
Vanguard Intermediate-Term Corporate Bond ETF92206C870SHS5,600$489,000thousands by filing date
iShares Gold Trust464285105ISHARES33,500$419,000thousands by filing date
SPDR GOLD TR78463V107GOLD SHS1,194$319,000thousands by filing date
IMMURON LTD45254U101SPONSORED ADR55,297$293,000thousands by filing date
WEB COM GROUP INC94733AAA2NOTE 1.000% 8/1250,000$247,000thousands by filing dateprincipal
EDITAS MEDICINE INC28106W103COM6,300$194,000thousands by filing date
CRISPR THERAPEUTICS AG NAMEN AKTH17182108Stock8,100$190,000thousands by filing date
GALECTIN THERAPEUTICS INC363225202COMMON STOCK50,000$167,000thousands by filing date
INTELLIA THERAPEUTICS INC45826J105COM7,200$138,000thousands by filing date
AKERS BIOSCIENCES INC00973E102COM1,032,000$138,000thousands by filing date
NEXTDECADE CORP65342K113COM15,200$126,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001140361-18-007714 superseded2018-02-14acceptance time not in the bulk data set
13F-HR/A 0001140361-18-013948this filing2018-03-19acceptance time not in the bulk data set